Eli Lilly Integrates Zepbound and Foundayo Into Hims & Hers, Completing Cash-Pay GLP-1 Platform
· techtimes.com · popularity 20/100 · 0 similar stories today · Pharmaceuticals & Medical Research (Health & Life Sciences)
Read the original at techtimes.com →
Summary
Eli Lilly's formal partnership with Hims & Hers puts Zepbound ($299/mo) and Foundayo ($149/mo) inside the telehealth platform as of November 6, 2026.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 4.